Liver transplant outcomes in HIV-infected patients: A systematic review and meta-analysis with synthetic cohort

AIDS

Volumn 25, Issue 6, 2011, Pages 777-786

  Cooper, Curtis ^a   Kanters, Steve ^b   Klein, Marina ^c   Chaudhury, Prosanto ^c   Marotta, Paul ^d   Wong, Phil ^c   Kneteman, Norman ^e   Mills, Edward J ^b,f  

^a UNIVERSITY OF OTTAWA   (Canada)

^b BRITISH COLUMBIA CENTRE FOR EXCELLENCE IN HIV AIDS   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

^e UNIVERSITY OF ALBERTA   (Canada)

^f UNIVERSITY OF OTTAWA   (Canada)

Author keywords

hepatitis C; HIV; liver; liver transplantation; meta analysis; transplant

Indexed keywords

ARTICLE; COHORT ANALYSIS; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER TRANSPLANTATION; META ANALYSIS; META ANALYSIS (TOPIC); MIXED INFECTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SURVIVAL; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ANTIVIRAL AGENTS; COHORT STUDIES; HEPATITIS C; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; LIVER TRANSPLANTATION; TREATMENT OUTCOME;

EID: 79953732034     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328344febb     Document Type: Article

References (103)

1. Belle SH, Porayko MK, Hoofnagle JH, Lake JR, Zetterman RK. Changes in quality of life after liver transplantation among adults. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Liver Transplantation Database (LTD). Liver Transpl Surg 1997; 3:93-104.
2. Ragni MV, Belle SH, Im K, Neff G, Roland M, Stock P, et al. Survival of human immunodeficiency virus-infected liver transplant recipients. J Infect Dis 2003; 188:1412-1420. (Pubitemid 37523925)
3. Stock PG, Roland ME, Carlson L, Freise CE, Roberts JP, Hirose R, et al. Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study. Transplantation 2003; 76:370-375.
4. Furukawa H, Todo S. Evolution of immunosuppression in liver transplantation: contribution of Cyclosporine. Transplant Proc 2004; 36 (2 Suppl):274S-284S.
5. Moser MA. Options for induction immunosuppression in liver transplant recipients. Drugs 2002; 62:995-1011. (Pubitemid 34533760)
6. Berenguer M. Natural history of recurrent hepatitis C. Liver Transplantation 2002; 8:S14-S18. (Pubitemid 35154038)
7. Testa G, Crippin JS, Netto GJ, Goldstein RM, Jennings LW, Brkic BS, et al. Liver transplantation for hepatitis C: recurrence and disease progression in 300 patients. Liver Transplantation 2000; 6:553-561.
8. Tolan DJ. Fibrosing cholestatic hepatitis after liver transplantation in a patient with hepatitis C and HIV infection. N Engl J Med 2001; 345:1781.
9. Samuel D, Bizollon T, Feray C, Roche B, Ahmed SN, Lemonnier C, Cohard M, et al. Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study. Gastroenterology 2003; 124:642-650. (Pubitemid 36268483)
10. Steinbrook R. Public solicitation of organ donors. N Engl J Med 2005; 353:441-444. (Pubitemid 41127286)
11. Gridelli B, Remuzzi G. Strategies for making more organs available for transplantation. N Engl J Med 2000; 343:404-410. (Pubitemid 30626124)
12. Keeffe EB. Liver transplantation: current status and novel approaches to liver replacement. Gastroenterology 2001; 120:749-762. (Pubitemid 32171644)
13. Duclos-Vallee JC, Féray C, Sebagh M, Teicher E, Roque-Afonso AM, Roche B, et al. Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus. Hepatology 2008; 47:407-417. (Pubitemid 351280708)
14. Prachalias AA, Pozniak A, Taylor C, Srinivasan P, Muiesan P, Wendon J, et al. Liver transplantation in adults coinfected with HIV. Transplantation 2001; 72:1684-1688. (Pubitemid 33096747)
15. Montori VM, Devereaux PJ, Adhikari NK, Burns KE, Eggert CH, Briel M, et al. Randomized trials stopped early for benefit: a systematic review. JAMA 2005; 294:2203-2209. (Pubitemid 41571138)
16. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7:177-188. (Pubitemid 17189972)
17. Fleiss JL. The statistical basis of meta-analysis. Stat Methods Med Res 1993; 2:121-145.
18. Wei LJ, Lin DY, Weissfeld L. Regression analysis of multivariate incomplete failure time data by modeling marginal distributions. J Am Stat Assoc 1989; 84:8.
19. Akaike H. A new look at the statistical model identification. IEEE Trans Automatic Control 1974; 19:7.
20. Duclos-Vallee JC, Vittecoq D, Teicher E, Feray C, Roque-Afonso AM, Lombès A, et al. Hepatitis Cvirus viral recurrence and liver mitochondrial damage after liver transplantation in HIV-HCV co-infected patients. J Hepatol 2005; 42:341-349. (Pubitemid 40254248)
21. Gastaca M, Mingol F, Valdiviesol A, Fernandez JR, Montejo M, Bustamante J, et al. Immunosupression and antiretroviral treatment after liver transplantation in HIV positive patients. In 13th Congress of the European Society for Organ Transplantation and the 15th Congress of the European Transplant Coordinators Organization; 2007: Prague, Czech Republic.
22. Moreno A, Bárcena R, Quereda C, Casado JL, Pérez- Elías MJ, Fortún J, et al. Safe use of raltegravir and sirolimus in an HIV-infected patient with renal impairment after orthotopic liver transplantation. AIDS 2008; 22:547-548. (Pubitemid 351317304)
23. Roland ME, Stock PG. Review of solid-organ transplantation in HIV-infected patients. Transplantation 2003; 75:425-429. (Pubitemid 36241132)
24. Gaitonde S, Vidanovic V, Ni H. Concomitant and fatal HHV-8+ multicentric Castleman's disease and Kaposi's sarcoma in the same lymph node of an HIV- liver transplant patient. Histopathology 2007; 50:954-958.
25. Jain AK, Venkataramanan R, Fridell JA, Gadomski M, Shaw LM, Ragni M, et al. Nelfinavir, a protease inhibitor, increases sirolimus levels in a liver transplantation patient: a case report. Liver Transpl 2002; 8:838-840. (Pubitemid 35012296)
26. Pea F, Tavio M, Pavan F, Londero A, Bresadola V, Adani GL, Furlanut M, et al. Drop in trough blood concentrations of tacrolimus after switching from nelfinavir to fosamprenavir in four HIV-infected liver transplant patients. Antivir Ther 2008; 13:739-742.
27. Teicher E, Vincent I, Bonhomme-Faivre L, Abbara C, Barrail A, Boissonnas A, et al. Effect of highly active antiretroviral therapy on tacrolimus pharmacokinetics in hepatitis C virus and HIV co-infected liver transplant recipients in the ANRS HC-08 study. Clin Pharmacokinet 2007; 46:941-952. (Pubitemid 47548643)
28. Tricot L, Teicher E, Peytavin G, Zucman D, Conti F, Calmus Y, et al. Safety and efficacy of raltegravir in HIV-infected transplant patients cotreated with immunosuppressive drugs. Am J Transplant 2009; 9:1946-1952.
29. Vibert E, Duclos-Vallee JC, Guettier C, Azoulay D, Castaing DX, Samuel D, et al. Results of liver transplantation for hepatocellular carcinoma in HIV/HCV and HIV/HVB coinfected patients. In The 59th Annual Meeting of the American Association for the Study of Liver Diseases; 2008: San Francisco, California.
30. Frassetto L, Baluom M, Jacobsen W, Christians U, Roland ME, Stock PG, Carlson L, et al. Cyclosporine pharmacokinetics and dosing modifications in human immunodeficiency virus-infected liver and kidney transplant recipients. Transplantation 2005; 80:13-17.
31. Frassetto LA, Browne M, Cheng A, Wolfe AR, Roland ME, Stock PG, Carlson L, et al. Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipients. Am J Transplant 2007; 7:2816-2820. (Pubitemid 350045781)
32. Gordon FH, Mistry PK, Sabin CA, Lee CA. Outcome of orthotopic liver transplantation in patients with haemophilia. Gut 1998; 42:744-749. (Pubitemid 28261067)
33. Baccarani U, Adani GL, Tavio M, Lorenzin D, Londero A, Bragantini F, et al. Liver Transplantation in HIV positive patients: a case control study. In Fifth ELITA-ELTR Winter Meeting; 2009. A°re, Sweden.
34. Castells L, Escartín A, Bilbao I, Len O, Allende H, Vargas V, et al. Liver transplantation in HIV-HCV coinfected patients: a case-control study. Transplantation 2007; 83:354-358.
35. Coffin CS, Berg CL, Dove LM, et al. Survival and risk of Hepatitis B Virus (HBV) recurrence in HIV-HVB coinfected live trans-plant recipients: preliminary findings from the HIV-TR study. In The 58th Annual Meeting of the American Association for the Study of Liver Diseases; 2007: Boston, Massachusetts.
36. de Vera ME, Dvorchik I, Tom K, Eghtesad B, Thai N, Shakil O, et al. Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C. Am J Transplant 2006; 6:2983-2993.
37. Di Benedetto F, Di Sandro S, De Ruvo N, Berretta M, Montalti R, Guerrini GP, et al. Human immunodeficiency virus and liver transplantation: our point of view. Transplant Proc 2008; 40:1965-1971.
38. Gastaca M, Montejo M, Castells L, Rafecas A, Rimola A, Bárcena R, et al. Results of the Spanish experience in HIV-infected patients treated with orthotopic liver transplantation: a prospective cohort of 89 cases (2002-2006). In American Transplant Congress; 2008: Toronto, Ontario, Canada.
39. Joshi D, Aluvihare V, Belgaumkar A, Suddle A, Pocock P, Heneghan MA, et al. UK liver transplant experience of HIV: long term outcomes. In 44th Annual Meeting of the European Association for the Study of the Liver (EASL). 2009. Copenhagen, Denmark.
40. Mindikoglu AL, Regev A, Magder LS. Impact of human immunodeficiency virus on survival after liver transplantation: analysis of United Network for Organ Sharing database. Transplantation 2008; 85:359-368. (Pubitemid 351322759)
41. Miro J. Liver transplantation in HIV-infected patients. In 2nd International Workshop on HIV and Hepatitis Co-infection; 2006. Amsterdam, Netherlands.
42. Miro J, Montejo M, Castells L, Meneu J, Rafecas A, Blanes M, et al. 5-year survival of HCV/HIV-co-infected liver transplant recipients: a case/control study. In 16th Conference on Retroviruses and Opportunistic Infections; 2009: Montreal, Quebec, Canada.
43. Neff GW, Bonham A, Tzakis AG, Ragni M, Jayaweera D, Schiff ER, et al. Orthotopic liver transplantation in patients with human immunodeficiency virus and end-stage liver disease. Liver Transpl 2003; 9:239-247. (Pubitemid 36322325)
44. Norris S, Taylor C, Muiesan P, Portmann BC, Knisely AS, Bowles M, et al. Outcomes of liver transplantation in HIV-infected individuals: the impact of HCV and HBV infection. Liver Transpl 2004; 10:1271-1278. (Pubitemid 39406083)
45. Pelletier SJ, Norman SP, Christensen LL, Stock PG, Port FK, Merion RM. Review of transplantation in HIV patients during the HAART era. Clin Transpl 2004; 63-82.
46. Roland ME, Barin B, Carlson L, Frassetto LA, Terrault NA, Hirose R, et al. HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes. Am J Transplant 2008; 8:355-365.
47. Sainz M, Baccarani U, Tavio M, Lorenzin D, Londero A, Pavan F, et al. Liver transplantation in HIV, 2 years experience case control analysis. In American Transplant Congress. 2007: San Francisco, California.
48. Schreibman I, Gaynor JJ, Jayaweera D, Pyrsopoulos N, Weppler D, Tzakis A, et al. Outcomes after orthotopic liver transplantation in 15 HIV-infected patients. Transplantation 2007; 84:697-705. (Pubitemid 47480654)
49. Teicher E, Duclos Vallee JC, Samuel D, Castaing D, Roque Afonso A, Sebagh M, et al. Liver transplantation in 88 HIV-infected patients. In 16th Conference on Retroviruses and Opportunistic Infections; 2009: Montreal, Quebec, Canada.
50. Testillano M, Fernandez JR, Suarez MJ, Gastaca M, Bustamante J, Pijoan JI, et al. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center. Transplant Proc 2009; 41:1041-1043.
51. Vennarecci G, Ettorre GM, Antonini M, Santoro R, Maritti M, Tacconi G, et al. First-line liver resection and salvage liver transplantation are increasing therapeutic strategies for patients with hepatocellular carcinoma and child a cirrhosis. Transplant Proc 2007; 39:1857-1860. (Pubitemid 47198834)
52. Antoniades C, Macdonald C, Knisely A, Taylor C, Norris S. Mitochondrial toxicity associated with HAART following liver transplantation in an HIV-infected recipient. Liver Transpl 2004; 10:699-702. (Pubitemid 38628233)
53. Antonini M, Ettorre GM, Vennarecci G, D'Offizi G, Narciso P, Del Nonno F, et al. Antiretrovirals and immunosuppressive drug interactions in a HIV-positive patient after liver transplantation. Hepatogastroenterology 2004; 51:646-648. (Pubitemid 38590931)
54. Bhagat V, Foont JA, Schiff ER, Regev A. Spontaneous clearance of hepatitis C virus after liver transplantation in two patients coinfected with hepatitis C virus and human immunodeficiency virus. Liver Transpl 2008; 14:92-95. (Pubitemid 351167994)
55. Buyse S, Vibert E, Sebagh M, Antonini T, Ichai P, Castaing D, et al. Liver transplantation for fulminant hepatitis related to nevirapine therapy. Liver Transpl 2006; 12:1880-1882. (Pubitemid 44911815)
56. Casavilla FA, Bianco G, Gasali F, Jacob N, Uchiumi L, Amante M, Macia E, et al. First two liver transplants in HIV patients in Argentina. In 11th Meeting of the International Liver Transplantation Society; 2005. Los Angeles, California.
57. Castells L, Esteban JI, Bilbao I, Vargas V, Allende H, Ribera E, et al. Early antiviral treatment of hepatitis C virus recurrence after liver transplantation in HIV-infected patients. Antivir Ther 2006; 11:1061-1070. (Pubitemid 44955182)
58. Di Benedetto F, De Ruvo N, Berretta M, Masetti M, Montalti R, Di Sandro S, et al. Hepatocellular carcinoma in HIV patients treated by liver transplantation. Eur J Surg Oncol 2008; 34: 422-427. (Pubitemid 351381293)
59. Dumortier J, Chiarello P, Adham M, Delafosse B, Chayvialle JA, Scoazec JY, Boillot O, et al. Specific risks of liver transplantation in patients co-infected with hepatitis C virus and human immunodeficiency virus. Clin Biol 2002; 26:1.
60. Geit M, Aubock J, Hubmann R, Biesenbach G, Muhlbacher F, Steininger R, Wutzelhofer F, et al. Liver transplantation in a hepatitis C, B and HIV co-infected patient: case report. In 6th International Congress on Drug Therapy in HIV infection; 2002. Glasgow, United Kingdom.
61. Gonzalez Alonso R, Bárcena R, Blesa C, Garcia M, Moreno A, Fortun J, et al. Liver transplantation in a patient coinfected with human immunodeficiency virus and hepatitis C virus. Transplant Proc 2003; 35:1846-1847. (Pubitemid 37093735)
62. Gow PJ, Mutimer D. Liver transplantation for an HIV-positive patient in the era of highly active antiretroviral therapy. AIDS 2001; 15:291-292. (Pubitemid 32142315)
63. Guaraldi G, Cocchi S, Codeluppi M, Di Benedetto F, Bonora S, Pecorari M, et al. Role of therapeutic drug monitoring in a patient with human immunodeficiency virus infection and end-stage liver disease undergoing orthotopic liver transplantation. Transplant Proc 2005; 37:2609-2610. (Pubitemid 41354687)
64. Halkic N, Bally F, Gillet M. Organ transplantation in HIV-infected patients. N Engl J Med 2002; 347:1801-1803; author reply 1801-3.
65. Jain AB, Venkataramanan R, Eghtesad B, Marcos A, Ragni M, Shapiro R, et al. Effect of coadministered lopinavir and ritonavir (Kaletra) on tacrolimus blood concentration in liver transplantation patients. Liver Transpl 2003; 9:954-960. (Pubitemid 37098844)
66. Jain AK, Venkataramanan R, Eghtesad B, Marcos A, Ragni M, Shapiro R, et al. The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients. Liver Transpl 2002; 8:841-845. (Pubitemid 35012297)
67. Jeng LB, Lee WC, Hung CM, Yu MC, Kuo LM, Chen MF. Liver transplantation in a patient with human immunodeficiency virus infection: a case report. Transplant Proc 2003; 35: 361.
68. Moreno A, Bárcena R, García-Gonzalez M, García-Hoz F, Quereda C, Casado JL, et al. Severe sirolimus-related inflammatory state anemia in an HIV+ liver transplant patient with calcineurin inhibitor renal insufficiency: a case report. Transplant Proc 2008; 40:3810-3812.
69. Moreno A, Quereda C, Barcena R. Successful pregnancy after orthotopic liver transplantation in a patient with HIV infection. N Engl J Med 2005; 353:2517-2518. (Pubitemid 41770179)
70. Moreno S, Fortún J, Quereda C, Moreno A, Pérez-Elías MJ, Martín-Dávila P, et al. Liver transplantation in HIV-infected recipients. Liver Transpl 2005; 11:76-81. (Pubitemid 40124445)
71. Muller NJ, Furrer H, Kaiser L, Hirschel B, Cavassini M, Fellay J, et al. HIV and solid organ transplantation: the Swiss experience. Swiss Med Wkly 2006; 136 (11-12):194-196.
72. Nowak P, Schvarcz R, Ericzon BG, Flamholc L, Sönnerborg A. Follow-up of antiretroviral treatment in liver transplant recipients with primary and chronic HIV type 1 infection. AIDS Res Hum Retroviruses 2003; 19:13-19. (Pubitemid 36398739)
73. Parkes R, McDonald C, Foxton M, Drejovic B, Nelson M, Knisely A, et al. Hepatic steatosis and lactic acidosis in an HIV/HCV co-infected patient following liver transplantation. In The XIV International AIDS Conference; 2002. Barcelona, Spain.
74. Polard E, Camus C, Abault AY, Turlin B, Arvieux C, Messner M, et al. Retransplantation for acute liver failure due to combined antiviral agents in an HIV-HCV coinfected liver transplant recipient. Transplantation 2005; 80:1136-1138. (Pubitemid 41611944)
75. Radecke K, Frühauf NR, Miller M, Ross B, Köditz R, Malagó M, et al. Outcome after orthotopic liver transplantation in five HIV-infected patients with virus hepatitis-induced cirrhosis. Liver Int 2005; 25:101-108. (Pubitemid 40298252)
76. Rafecas A, Rufí G, Figueras J, Fabregat J, Xiol X, Ramos E, et al. Liver transplantation without steroid induction in HIV-infected patients. Liver Transpl 2004; 10:1320-1323. (Pubitemid 39406090)
77. Ragni MV, Dodson SF, Hunt SC, Bontempo FA, Fung JJ, et al. Liver transplantation in a hemophilia patient with acquired immunodeficiency syndrome. Blood 1999; 93:1113-1114.
78. Ricciardi S, Van Wanzeele F, Troisi R. Infections and immunosuppression as specific problems in a HIV + patient transplanted for end-stage alcoholic cirrhosis. Acta Chir Belg 2007; 107:215-218.
79. Roland ME, Adey D, Carlson LL, Terrault NA. Kidney and liver transplantation in HIV-infected patients: case presentations and review. AIDS Patient Care STDS 2003; 17:501-507.
80. Schliefer K, Paar WD, Aydemir G, Wolff M, Rockstroh JK, Spengler U, Sauerbruch T. Orthotopic liver transplantation in a 33-year-old patient with fulminant hepatitis B and HIV infection. Dtsch Med Wochenschr 2000; 125:3.
81. Schonder KS, Shullo MA, Okusanya O. Tacrolimus and lopinavir/ ritonavir interaction in liver transplantation. Ann Pharmacother 2003; 37:1793-1796. (Pubitemid 37466573)
82. Schvarcz R, Rudbeck G, Söderdahl G, Ståhle L. Interaction between nelfinavir and tacrolimus after orthoptic liver transplantation in a patient coinfected with HIV and hepatitis C virus (HCV). Transplantation 2000; 69:2194-2195. (Pubitemid 30395060)
83. Schvarcz R, Soderdahl G. Successful hepatitis C virus treatment in patients coinfected with HIV after liver transplantation. Transplantation 2005; 79:853. (Pubitemid 40546208)
84. Sheikh AM, Wolf DC, Lebovics E, Goldberg R, Horowitz HW. Concomitant human immunodeficiency virus protease inhibitor therapy markedly reduces tacrolimus metabolism and increases blood levels. Transplantation 1999; 68:307-309. (Pubitemid 29360297)
85. Sugawara Y, Ohkubo T, Makuuchi M, Kimura S, Morisawa Y, Tachikawa N, Oka S, et al. Living-donor liver transplantation in an HIV-positive patient with hemophilia. Transplantation 2002; 74:1655-1656. (Pubitemid 36014247)
86. Tateo M, Roque-Afonso AM, Antonini TM, Medja F, Lombes A, Jardel C, et al. Long-term follow-up of liver transplanted HIV/hepatitis B virus coinfected patients: perfect control of hepatitis B virus replication and absence of mitochondrial toxicity. AIDS 2009; 23:1069-1076.
87. Tateo M, Sebagh M, Bralet MP, Teicher E, Azoulay D, Mallet V, et al. A new indication for liver transplantation: nodular regenerative hyperplasia in human immunodeficiency virus-infected patients. Liver Transpl 2008; 14:1194-1198.
88. Terrault NA, Carter JT, Carlson L, Roland ME, Stock PG. Outcome of patients with hepatitis B virus and human immunodeficiency virus infections referred for liver transplantation. Liver Transpl 2006; 12:801-807.
89. Tolan DJ, Davies MH, Millson CE. Fibrosing cholestatic hepatitis after liver transplantation in a patient with hepatitis C and HIV infection. N Engl J Med 2001; 345:1781.
90. Turkova A, Ball C, Gilmour-White S, Rela M, Mieli-Vergani G. A paediatric case of acute liver failure associated with efavirenz- based highly active antiretroviral therapy and effective use of raltegravir in combination antiretroviral treatment after liver transplantation. J Antimicrob Chemother 2009; 63:623-625.
91. Vogel M, Voigt E, Michaelis HC, Sudhop T, Wolff M, Türler A, et al. Management of drug-to-drug interactions between cyclosporine A and the protease-inhibitor lopinavir/ritonavir in liver-transplanted HIV-infected patients. Liver Transpl 2004; 10:939-944. (Pubitemid 38979268)
92. Vogel M, Voigt E, Schäfer N, Goldmann G, Schwarz N, Kalff JC, et al. Orthotopic liver transplantation in human immunodeficiency virus (HIV)-positive patients: outcome of 7 patients from the Bonn cohort. Liver Transpl 2005; 11:1515-1521. (Pubitemid 43072627)
93. Wojcik K, Vogel M, Voigt E, Speidel N, Kalff JC, Goldmann G, et al. Antiviral therapy for hepatitis C virus recurrence after liver transplantation in HIV-infected patients: outcome in the Bonn cohort. AIDS 2007; 21:1363-1365. (Pubitemid 46883493)
94. Burroughs AK, Sabin CA, Rolles K, Delvart V, Karam V, Buckels J, et al. 3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome. Lancet 2006; 367:225-232. (Pubitemid 43107667)
95. Patient Survival by Age and by Time since First Transplant of This Organ Type. Scientific Registry of Transplant Recipients [Webpage] 2010 01/12/2010 [cited 2010 January 29]; Available from: http://www.ustransplant.org/csr/ current/national-Viewer.aspx?o=LI&t=11.
96. Lok AS. Prevention of recurrent hepatitis B postliver transplantation. Liver Transpl 2002; 8 (10 Suppl 1):S67-S73. (Pubitemid 35154046)
97. Cooper CL, DeForest J, Gill J, Lalonde R, Canadian HIV Trials Network (CTN) Co-Infection Core Group. Barriers preventing liver transplantation in Canadians with HIV-infection-perceptions of HIV specialists. Can J Gastroenterol 2007; 21:179-182. (Pubitemid 47061616)
98. Graham CS, Baden LR, Yu E, Mrus JM, Carnie J, Heeren T, Koziel MJ. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a metaanalysis. Clin Infect Dis 2001; 33:562-569. (Pubitemid 32709592)
99. Monga HK, Rodriguez-Barradas MC, Breaux K, Khattak K, Troisi CL, Velez M, Yoffe B, et al. Hepatitis C virus infection-related morbidity and mortality among patients with human immunodeficiency virus infection. Clin Infect Dis 2001; 33:240-247. (Pubitemid 32643340)
100. Rodriguez-Luna H, Douglas DD. Natural history of hepatitis C following liver transplantation. Curr Opin Infect Dis 2004; 17:363-371. (Pubitemid 39037532)
101. Halpern SD, Asch DA, Shaked A, Stock PG, Blumberg E. Determinants of transplant surgeons' willingness to provide organs to patients infected with HBV, HCV or HIV. Am J Transplant 2005; 5:1319-1325. (Pubitemid 40839420)
102. Samuel D, Bizollon T, Feray C, Roche B, Ahmed SN, Lemonnier C, et al. Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study. Gastroenterology 2003; 124:642-650. (Pubitemid 36268483)
103. Di Benedetto F, Di Sandro S, De Ruvo N, Berretta M, Masetti M, Montalti R, et al. Kaposi's sarcoma after liver transplantation. J Cancer Res Clin Oncol 2008; 134:653-658. (Pubitemid 351506416)